These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32239920)

  • 1. Rapid
    Moore JH; Honrado C; Stagnaro V; Kolling G; Warren CA; Swami NS
    ACS Infect Dis; 2020 May; 6(5):1000-1007. PubMed ID: 32239920
    [No Abstract]   [Full Text] [Related]  

  • 2. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
    Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
    Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains.
    Schoster A; Kokotovic B; Permin A; Pedersen PD; Dal Bello F; Guardabassi L
    Anaerobe; 2013 Apr; 20():36-41. PubMed ID: 23471038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy.
    Maziade PJ; Ship N; Sniffen JC; Goldstein EJC
    Clin Infect Dis; 2021 Oct; 73(8):1524-1527. PubMed ID: 33966076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanisms and safety of probiotics against toxigenic
    Liu D; Zeng L; Yan Z; Jia J; Gao J; Wei Y
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):967-975. PubMed ID: 32520637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome analysis of the Clostridioides difficile response to a specific lactobacilli probiotic formulation: explanations for its mechanisms of action.
    Masset Z; Gunaratnam S; Millette M; McFarland LV; Lacroix M
    J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36898672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking Inhibitory Alterations during Interstrain
    Su YH; Rohani A; Warren CA; Swami NS
    ACS Infect Dis; 2016 Aug; 2(8):544-551. PubMed ID: 27547818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains?
    Tejero-Sariñena S; Barlow J; Costabile A; Gibson GR; Rowland I
    Anaerobe; 2013 Dec; 24():60-5. PubMed ID: 24091275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying bacterial spore germination by single-cell impedance cytometry for assessment of host microbiota susceptibility to Clostridioides difficile infection.
    Moore JH; Salahi A; Honrado C; Warburton C; Warren CA; Swami NS
    Biosens Bioelectron; 2020 Oct; 166():112440. PubMed ID: 32745926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics in clostridium difficile Infection.
    Na X; Kelly C
    J Clin Gastroenterol; 2011 Nov; 45 Suppl(Suppl):S154-8. PubMed ID: 21992956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro.
    Trejo FM; Pérez PF; De Antoni GL
    Antonie Van Leeuwenhoek; 2010 Jun; 98(1):19-29. PubMed ID: 20232250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro.
    Hopkins MJ; Macfarlane GT
    Appl Environ Microbiol; 2003 Apr; 69(4):1920-7. PubMed ID: 12676665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study.
    Fredua-Agyeman M; Stapleton P; Basit AW; Beezer AE; Gaisford S
    Int J Pharm; 2017 Jan; 517(1-2):96-103. PubMed ID: 27923699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro determination of inhibitory effects of probiotic strains on Clostridioides difficile.
    Yalçin GT; Tosun MN; Demirel Zorba NN
    Anaerobe; 2023 Jun; 81():102737. PubMed ID: 37217116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of probiotics in reducing Clostridioides difficile virulence: Interference with quorum sensing systems.
    Gunaratnam S; Millette M; McFarland LV; DuPont HL; Lacroix M
    Microb Pathog; 2021 Apr; 153():104798. PubMed ID: 33609647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2'-Fucosyllactose inhibits proliferation of
    Wiese M; Schuren FHJ; Smits WK; Kuijper EJ; Ouwens A; Heerikhuisen M; Vigsnaes L; van den Broek TJ; de Boer P; Montijn RC; van der Vossen JMBM
    Front Cell Infect Microbiol; 2022; 12():991150. PubMed ID: 36389156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
    Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
    Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Quinolone- and Multi-Drug-Resistant Clostridioides Difficile Strains by Multi Strain Synbiotics-An Option for Diarrhea Management in Nursing Facilities.
    Sommermeyer H; Pituch HM; Wultanska D; Wojtyla-Buciora P; Piatek J; Bernatek M
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34070727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro and In Vivo Anti-
    Islam MI; Seo H; Redwan A; Kim S; Lee S; Siddiquee M; Song HY
    J Microbiol Biotechnol; 2022 Jan; 32(1):46-55. PubMed ID: 34675143
    [No Abstract]   [Full Text] [Related]  

  • 20. Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells.
    Boonma P; Spinler JK; Venable SF; Versalovic J; Tumwasorn S
    BMC Microbiol; 2014 Jul; 14():177. PubMed ID: 24989059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.